Figure 10 | Scientific Reports

Figure 10

From: Identification and validation of candidate clinical signatures of apolipoprotein L isoforms in hepatocellular carcinoma

Figure 10

Prognosis-predicting nomograms and inner validation for 1, 3, and 5 years in the TCGA cohort. (A–B): Overall survival-predicting nomogram using tumor stage, radical resection, hepatitis B virus infection status, and APOL6 expression and inner validation for 1, 3, and 5 years. (C–D): Recurrence-free survival-predicting nomogram using tumor stage, radical resection, hepatitis B virus infection status, vascular invasion, and APOL3 and APOL4 expression and inner validation for 1, 3, and 5 years.

Back to article page